Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | Repligen 136 | CTRPv2 | pan-cancer | AAC | -0.016 | 0.7 |
mRNA | Nilotinib | FIMM | pan-cancer | AAC | 0.074 | 0.7 |
mRNA | Nilotinib | GDSC1000 | pan-cancer | AAC | 0.017 | 0.7 |
mRNA | BIBR-1532 | CTRPv2 | pan-cancer | AAC | 0.016 | 0.7 |
mRNA | Vinorelbine | GDSC1000 | pan-cancer | AAC | -0.016 | 0.7 |
mRNA | BRD-K58730230 | CTRPv2 | pan-cancer | AAC | 0.031 | 0.7 |
mRNA | erismodegib | CTRPv2 | pan-cancer | AAC | -0.016 | 0.7 |
mRNA | AZD7762 | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |
mRNA | neratinib | CTRPv2 | pan-cancer | AAC | -0.015 | 0.7 |
mRNA | Gefitinib | CTRPv2 | pan-cancer | AAC | 0.016 | 0.7 |